TaiMed Biologics Inc. (TPEX:4147)
Taiwan · Delayed Price · Currency is TWD 62.20
-0.90 (-1.43%)
Aug 19, 2026, 9:48 AM CST
TaiMed Biologics Market Cap
TaiMed Biologics has a market cap or net worth of 17.24 billion as of August 18, 2026. Its market cap has decreased by -20.53% in one year.
Market Cap
17.24B
Enterprise Value
16.08B
Revenue
619.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
62.20
ChartMarket Cap Chart
Since June 28, 2010, TaiMed Biologics's market cap has increased from 2.58B to 17.24B, an increase of 568.06%. That is a compound annual growth rate of 12.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 17.24B | 3.10% |
| Dec 31, 2025 | 16.72B | -28.81% |
| Dec 31, 2024 | 23.48B | 13.20% |
| Dec 29, 2023 | 20.75B | 16.27% |
| Dec 30, 2022 | 17.84B | 0.17% |
| Dec 30, 2021 | 17.81B | -16.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CHO Pharma | 24.83B |
| Oneness Biotech | 22.48B |
| Sunmax Biotechnology | 21.00B |
| Medigen Vaccine Biologics | 16.57B |
| Ever Supreme Bio Technology | 15.11B |
| EirGenix | 14.75B |
| Lumosa Therapeutics | 14.39B |
| ACRO Biomedical | 12.39B |